ADAM9 and breast cancer: ADAM9 (A Disintegrin and Metalloproteinase 9) is a cell-surface membrane glycoprotein that is overexpressed in a number of cancers, including gastric cancer [21], lung cancer [16, 22–24], breast cancer [25], prostate cancer [26], and liver cancer [27].